Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 4, Number 2—June 1998

Perspective

Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives

Ashok RattanComments to Author , Awdhesh KaliaComments to Author , and Nishat Ahmad
Author affiliations: All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India

Main Article

Figure 2

Mechanism of action of isoniazid (INH); acquisition of resistance and combating oxidative stress. DPR, divergent promoter region.

Figure 2. Mechanism of action of isoniazid (INH); acquisition of resistance and combating oxidative stress. DPR, divergent promoter region.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO